Tecomet, a Wilmington, Massachusetts-based contract manufacturer and portfolio company of Boston-based Charlesbank Capital Partners, has acquired the assets of Teleflex Medical OEM's Orthopedics business, based in Kenosha, Wisconsin. Specializing in custom surgical instruments and implants, the acquired business will complement Tecomet's existing portfolio of contract manufactured medical implants. The acquired business includes the Beere Medical® brand of standard and custom instruments, precision ratchet drivers, torque wrenches and molded silicone handles as well as one of the world's largest collections of high-quality, forged surgical instruments for orthopedic and spinal procedures.
"Adding the Kenosha operation to Tecomet's base will significantly enhance our offerings to existing Kenosha and Tecomet customers. We are impressed with the workforce in Kenosha and look forward to helping them build on the solid platform they have created," stated Bill Dow, President and CEO of Tecomet.
The Kenosha manufacturing plant, management team, trained workforce, and ISO13485 certified Quality Management System will remain in Kenosha and will now operate under the Tecomet trade name.
Tecomet, Inc. is a leading contract manufacturing, engineering and technology company specializing in net shape forging, precision machining, photochemical etching, surface texturing, vacuum brazing, laser and electron beam welding, and rapid prototyping. Tecomet is ISO13485, ISO9001, and AS9100 certified and supplies precision engineered components and assemblies to the medical, aerospace/defense, and commercial/industrial markets, with special emphasis on orthopedic, cranial maxillofacial, trauma, and spinal implants and related instrumentation. For more information about Tecomet, please visit www.tecomet.com.
About Charlesbank Capital Partners
Based in Boston and New York, Charlesbank Capital Partners is a middle-market private equity investment firm managing more than $2 billion of capital. Charlesbank focuses on management-led buyouts and growth capital financings, typically investing $50 million to $150 million per transaction in companies with enterprise values of $100 million to $750 million. The firm seeks to partner with strong management teams to build companies with sustainable competitive advantages and excellent prospects for growth. For more information, visit www.charlesbank.com.